In addition, a higher BMI was significantly associated with the NAFLD, lean NAFLD, and abnormal levels of ALT and AST in the current study (Supplementary Tables S1–S4, respectively). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.